Ser/Thr phosphorylation of insulin receptor substrate IRS-1 regulates insulin signaling, but the relevant phosphorylated residues and their potential functions during insulin-stimulated signal transduction are difficult to resolve. We used a sequence-specific polyclonal antibody directed against phosphorylated Ser 302 to study IRS-1-mediated signaling during insulin and insulinlike growth factor IGF-I stimulation. Many insulin signals are produced through tyrosine phosphorylation of the insulin receptor substrate (IRS) 1 -proteins or other scaffold proteins, including Shc, Cbl, APS, and SH2B, Gab1/2, and Dock1/2 (1). Although the role of each of these substrates merits attention, work with transgenic mice suggests that many insulin responses, especially those that are associated with somatic growth and carbohydrate metabolism, are mediated through IRS-1 or IRS-2 (2-4). IRS-proteins are composed of multiple interaction domains and phosphorylation motifs, but they appear to lack intrinsic catalytic activities (5). All IRS-proteins contain an NH 2 -terminal pleckstrin homology domain followed by a phosphotyrosine binding domain. These domains couple the IRS-protein to the activated receptors for insulin, IGF-I, IL-4 and others (6). Multiple tyrosine phosphorylation sites in the COOH terminus recruit various enzymes (PI3K, SHP2, or fyn) or adapter proteins (Grb-2, nck, crk, shb, and others) that promote carbohydrate and lipid metabolism, cell growth and survival, and the function of specialized neuroendocrine tissues that promote nutrient homeostasis and female fertility (5, 7).
Many insulin signals are produced through tyrosine phosphorylation of the insulin receptor substrate (IRS) 1 -proteins or other scaffold proteins, including Shc, Cbl, APS, and SH2B, Gab1/2, and Dock1/2 (1) . Although the role of each of these substrates merits attention, work with transgenic mice suggests that many insulin responses, especially those that are associated with somatic growth and carbohydrate metabolism, are mediated through IRS-1 or IRS-2 (2-4). IRS-proteins are composed of multiple interaction domains and phosphorylation motifs, but they appear to lack intrinsic catalytic activities (5) . All IRS-proteins contain an NH 2 -terminal pleckstrin homology domain followed by a phosphotyrosine binding domain. These domains couple the IRS-protein to the activated receptors for insulin, IGF-I, IL-4 and others (6) . Multiple tyrosine phosphorylation sites in the COOH terminus recruit various enzymes (PI3K, SHP2, or fyn) or adapter proteins (Grb-2, nck, crk, shb, and others) that promote carbohydrate and lipid metabolism, cell growth and survival, and the function of specialized neuroendocrine tissues that promote nutrient homeostasis and female fertility (5, 7) .
Insulin plays a pivotal role in metabolic regulation because it promotes nutrient influx and storage in muscle and adipocytes and inhibits hepatic gluconeogenesis. Although insulin is the principal activator, heterologous signals reflecting nutrient availability or physiological stress modulate insulin signaling. Dysregulation of these heterologous signals contributes to peripheral insulin resistance, metabolic dysregulation, and diabetes (2) . Several mechanisms have been proposed to explain heterologous regulation of the insulin signaling cascade, including cytokine-induced serine phosphorylation or degradation of the IRS-proteins, or direct inhibition of the insulin receptor. IRS-1 contains more than 20 potential serine phosphorylation sites in amino acid sequence motifs that are recognized by various kinases, including protein kinase A, protein kinase B/Akt, protein kinase C, ERK1/2, Rho kinase and mTOR (8 -10) . Many studies suggest that serine phosphorylation causes insulin resistance by blocking the interaction between IRS-1 and the activated insulin receptor, inhibiting the phosphorylation of specific tyrosine residues, or promoting IRS-1 degradation (11) (12) (13) . Previous work from our laboratory shows that JNK-mediated phosphorylation of Ser 307 inhibits coupling of IRS-1 to the activated insulin receptor, which reduces insulin-stimulated tyrosine phosphorylation and insulin signaling (14, 15) . By contrast, here we show that an adjacent residue, Ser 302 , is required for insulin-stimulated tyrosine phosphorylation of IRS-1 and that its phosphorylation might link insulin signaling to nutrient availability.
MATERIALS AND METHODS

Antibodies and Reagents-Phosphospecific
Ser 302 antibodies were made by injecting rabbits with a synthetic peptide designed to contain phosphorylated Ser 302 (Boston Biomolecule). Anti-phosphotyrosine antibody was purchased from Transduction Laboratories. Antibodies against IRS-1 and p85 have been described (16) . Antibodies against phosphotyrosine, phospho-Akt, Akt, phospho-p70
S6K
, p70
, phosphoribosomal S6, ribosomal S6, phospho-4E-BP-1, phospho-GSK-3␤ and GSK-3 were purchased from Cell Signaling Technology. JNK antibodies were from Santa Cruz. Monoclonal antibodies against full-length IRS-1 were made in the laboratory. All inhibitors, cytokines, and growth factors were purchased from Calbiochem. A BrdUrd cell proliferation kit was purchased from Oncogene Research Products. Dulbecco's phosphate-buffered saline (DPBS), 50ϫ amino acid solution, and dextrose were from Invitrogen. Mouse embryonic fibroblasts (MEFs) were from Roger Davis.
Mutagenesis-IRS-1 point mutants for Ser 302 to Ala were generated using the Stratagene QuikChange XL site-directed mutagenesis method.
Cell Culture-IL-3-dependent 32D mouse myeloid cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 5% WEHI (IL-3), and 5 mM histidinol. 32D express a few endogenous insulin receptors but no endogenous IRS-proteins. Overexpression of IRS-1 in 32D cells reconstitutes many aspects of the insulin signaling pathway (17, 18) . These cells were starved for at least 4 h before treatment with insulin/IGF-I. All inhibitors were added 30 min before insulin or growth factor treatment at 37°C. 32D/IRS-1 and 32D/A302 IRS-1 (mutant IRS-1 protein containing an alanine substitution for Ser 302 ) were generated by electroporation and selected in histidinol as described previously (19) . Chinese hamster ovary (CHO) cells were maintained in Ham's F-12 medium supplemented with 10% fetal bovine serum. MEFs were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. CHO and MEF cells were starved for at least 12 h before inhibitor or insulin treatment.
Cell Lysis, Immunoprecipitation, and Western Analysis-32D cells were starved for 4 h in serum-free medium and stimulated with insulin for the indicated times. Cells were lysed in 50 mM Tris, pH 7.4, containing 130 nM NaCl, 5 mM EDTA, 1% Nonidet P-40, 100 mM NaF, 50 mM ␤-glycerophosphate, 100 M vanadate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml aprotinin. Immunoprecipitations were performed for 2 h at 4°C followed by collection on protein A/G-Sepharose. Lysates and immunoprecipitates were resolved by SDS-PAGE and transferred to nitrocellulose. Proteins were detected by immunoblotting with specific antibodies. A similar protocol was used for CHO and MEF cells. Muscle samples from mice were prepared as in Ref. 20 .
Amino F-12 medium as described previously. For the starvation of amino acids, cells were starved for at least 12 h in serum-free medium. Cells were then washed twice with and incubated in the same buffer for 2 h. A 1ϫ final concentration of amino acids or 5 mM of D-glucose (Glc) were added to the cells for 30 min followed by a 15-min treatment with insulin (21) .
Cell Proliferation Assay-Insulin/IGF-I-stimulated proliferation of 32D cells was assayed according to the company's manual (Oncogene Research Products). Briefly, 32D cells in log phase growth were washed twice in phosphate-buffered saline and counted by the trypan blue exclusion method using a hematocytometer. 100 l of cells at a density of 1 ϫ 10 4 cells/ml were seeded into a 96-well culture dish. Cells were allowed to grow for 24 h. BrdUrd label was added to the cells for 6 h at 37°C. BrdUrd incorporation was measured by enzyme-linked immunosorbent assay using a dual wavelength spectrometric plate reader (A 450 -540 nm ). As controls, we included a blank containing only tissue culture medium and a background control containing only cells that were not labeled with BrdUrd. Each condition was done in triplicate, and the average absorbance values were used in plotting the results.
RESULTS
Insulin/IGF-I Stimulates Ser
302 Phosphorylation-To study serine phosphorylation of IRS-1, we raised sequence-specific polyclonal antibodies against 17-amino acid peptides containing putative serine phosphorylation sites in rat IRS-1. One of these antibodies was directed against pSer 302 and designated ␣-pS 302 . The ␣-pS 302 immunoblotted IRS-1 extracted from insulin or IGF-I-stimulated 32D/IRS-1 cells, 3T3-L1 adipocytes, and CHO IR /IRS-1 cells. Platelet-derived growth factor had a weak effect in 3T3-L1 adipocytes, and epidermal growth factor and tumor necrosis factor-␣ did not promote Ser 302 phosphorylation ( Fig. 1, a-c) . Ser 302 phosphorylation was detected 1 min after insulin stimulation of 32D/IRS-1 cells, reached a maximum within 30 min, but was barely detected after 2 h (Fig. 1d) . Moreover, Ser 302 was phosphorylated in IRS-1 isolated from muscles of insulin-stimulated mice, suggesting that Ser 302 phosphorylation might be physiologically relevant (Fig. 1e) .
We conducted peptide competition and site-directed mutagenesis experiments to establish the specificity of the ␣-pS 302 . The phosphopeptide used to produce ␣-pS 302 (Fig. 2 , a and b) completely prevented immunoblotting of IRS-1 from IRS-1 cells were treated with 100 nM insulin for the indicated times, and lysates were blotted directly with ␣-PY-20 and ␣-IRS-1. The phospho-IRS-1 band was normalized to the corresponding IRS-1 band (total) using ImageQuant, and the results are reported as percentages of the maximum value obtained. These results are representative of three independent experiments using three different clones. Standard deviations are less than 5% in each case, and error bars are omitted for clarity. c, 32D, 32D/IRS-1, and 32D/A302
IRS-1 cells were treated with 100 nM insulin for the indicated times. IRS-1 immunoprecipitates were blotted with ␣p85 and IRS-1 antibodies. Lysates were immunoblotted with p85 antibody.
insulin-stimulated 32D/IRS-1 cells (Fig. 2c) . The unphosphorylated peptide at best weakly inhibited immunoblotting, suggesting that the phosphoserine residue was an important determinant of specificity (Fig. 2c) (Fig. 3, a and b) . Consistent with reduced tyrosine phosphorylation, A302
IRS-1 associated weakly with p85 during insulin stimulation (Fig. 3c) S6K /S6 and mTOR/4E-BP1 cascades. As shown previously, IRS-1 was required for insulin-stimulated phosphorylation of Akt in 32D cells, which is consistent with the binding and activation of PI3K by IRS-1 during insulin stimulation (Fig. 4a) . However, insulin stimulated normally Akt phosphorylation in 32D/A302
IRS-1 cells, even though tyrosine phosphorylation of A302 IRS-1 and p85 recruitment was significantly reduced during insulin stimulation (Fig. 4a) . Akt phosphorylates GSK-3␤ on Ser 9 , which can be detected with a phosphospecific antibody (23 ribosomal protein, ␣-S6 ribosomal protein, ␣-phospho-4E-BP1 Thr 37 , and ␣-4E-BP1.
impair IRS-1-mediated activation of the Akt/GSK-3␤ cascade during insulin stimulation (Fig. 4a) .
The activation of p70 S6K was investigated during insulin stimulation by immunoblotting with a phosphospecific antibody against pThr 389 . As shown previously, insulin failed to stimulate p70 S6K phosphorylation in 32D cells, whereas it was strongly phosphorylated in 32D/IRS-1 cells, especially after 30 min of insulin stimulation (Fig. 4b) . The ribosomal protein S6 and the regulatory protein 4E-BP1 are substrates of p70
S6K
and mTOR, respectively, and both proteins were phosphorylated during insulin stimulation of 32D/IRS-1 cells (Fig. 4b) . However, insulin weakly stimulated p70 S6K phosphorylation in 32D/A302
IRS-1 cells, and the phosphorylation of S6 and 4E-BP1 was barely detected (Fig. 4b) phosphorylation in MEFs, whereas PD98059 (mitogen-activated protein kinase cascade) had no inhibitory effect; these inhibitors had the expected effects on p70 S6K , ERK1/2, and Akt phosphorylation (Fig. 5c) . Similar results were obtained with 32D, CHO cells, and 3T3-L1 adipocytes (data not shown). Thus, mTOR-regulated pathways promote insulin-stimulated Ser 302 phosphorylation.
Previous results showed that activation of mTOR by mitogens or insulin is modulated by nutrient availability, including amino acids or glucose (25, 26) . We investigated the effect of amino acid and glucose starvation on Ser 302 phosphorylation to establish further whether an mTOR-mediated pathway is involved. Incubation of CHO IR /IRS-1 cells in glucose and amino acid-free medium (DPBS) reduced basal and insulin-stimulated Ser 302 phosphorylation (Fig. 6, a and b) . Consistent with a role for the mTOR cascade, the addition of amino acids or glucose restored basal and insulin-stimulated Ser 302 phosphorylation (Fig. 6, a and b) . Insulin-stimulated AKT phosphorylation was not reduced in glucose/amino acid-free medium, suggesting that the early steps of insulin signaling were not inhibited, and sufficient ATP exists in the starved cells to mediate kinase activities (Fig. 6b) . Rapamycin or LY294002 inhibited amino acid-stimulated phosphorylation of Ser 302 , whereas PD98059 had no effect, which was consistent with a role for the mTOR cascade during nutrient and insulin-stimulated Ser 302 phosphorylation (Fig. 6c ). Although our results suggest that kinases in the mTOR cascade promote Ser 302 phosphorylation, mTOR itself is probably not involved. We treated cells with a relatively high concentration of okadaic acid, which inhibits protein phosphatase 2A and other related phosphatases (27) . As expected, okadaic acid increased Ser 302 phosphorylation; however, the stimula- tory effect of okadaic acid was not inhibited by either rapamycin or LY294002 (Fig. 6d) . We conclude that mTOR is not a direct Ser 302 kinase. Ser 302 Promotes Insulin-stimulated Mitogenesis-One of the main biological functions of insulin/IGF-I is to promote cell proliferation, and the activation of Akt, p70 S6K , and 4E-BP1 plays an important role (28 -31) . Because these signals are regulated differentially by A302
IRS-1 , we compared insulin/ IGF-I-stimulated DNA synthesis in 32D/IRS-1 and 32D/ A302 IRS-1 cells. As shown previously, insulin or IGF-I failed to promote DNA synthesis in wild type 32D cells; however, expression of IRS-1 mediated insulin/IGF-I-stimulated DNA synthesis (Fig. 7) . Because insulin receptors are nearly absent in 32D cells, a high concentration of insulin was required to stimulate DNA synthesis in 32D/IRS-1 cells. However, insulin or IGF-I stimulation of DNA synthesis was significantly reduced in 32D/A302
IRS-1 cells (Fig. 7) .
DISCUSSION
Our results show that Ser 302 in rat/mouse IRS-1 is phosphorylated rapidly during insulin stimulation. Although we have not identified the kinase, inhibitor experiments and short term glucose/amino acid starvation suggest that mTOR-regulated kinases are involved. TOR is thought to act as a sensor of ambient amino acid concentrations (32, 33) . Insulin-stimulated Ser 302 phosphorylation is reduced when glucose/amino acids are removed from the culture medium and restored to normal when these nutrients are provided. These results reveal a potential mechanism that coordinates IRS-1-mediated insulin action with nutrient availability.
Replacing Ser 302 with alanine (A302 IRS-1 ) provides the strongest evidence that Ser 302 is a cornerstone of IRS-1 function. A302
IRS-1 is expressed normally in cells, but it is phosphorylated poorly on tyrosine residues and interacts weakly with p85 during insulin stimulation. Previous work from our laboratory and elsewhere establishes a close relation between p85 binding to IRS-1 and activation of the PI3K. This relation is especially clear in 32D and 32D IR cells that lack endogenous IRS-proteins (19, 34, 35) . Phospholipid products generated from PI3K activation activate various serine kinases, including Akt and certain atypical protein kinase C isoforms (36) . Akt plays an important role in insulin action as it phosphorylates GSK-3␤, the antiapoptotic protein BAD, the forkhead transcription factor Foxo1, and other targets (37, 38) . In 32D or 32D IR cells, expression of recombinant IRS-1 is a prerequisite for activation of Akt by insulin (19) . However, expression of IRS-1 rather than its ability to activate PI3K might be the critical step in Akt activation in 32D cells. Here we show that A302 IRS-1 barely binds to p85, whereas it mediates insulinstimulated phosphorylation of Akt and the activation of the Akt/GSK-3␤ cascade normally. This result is consistent with early findings that a truncated IRS-1 protein composed of residues 1-309 failed to promote PI3K activity whereas activating Akt during insulin stimulation (19) . Moreover, similar conclusions have emerged during that study of various models of insulin resistance, where PI3K is poorly activated whereas Akt is activated normally (39, 40) .
Insulin/IGF signaling plays an important role in somatic growth, and disruption of IRS-1 results in mice that reach 50% or their expected size (41) . Body growth depends upon mitogenesis and protein synthesis. Translational control by amino acid-dependent signaling appears to be integrated with the insulin stimulated PI3K signaling through the activation of TOR, the target of rapamycin (17, 26) . Like Akt activation, the expression of IRS-1 is absolutely required for insulin stimulation of the p70 S6K /S6 pathway and inactivation of 4E-BP1; however, in this case the activation of PI3K is essential (17, 34) . Unlike our results with the Akt/GSK-3␤ cascade, A302 fails to mediate the insulin stimulation of the p70 S6K /S6 pathway and phosphorylation of 4E-BP1. The truncated IRS-1-protein composed of residues 1-309 also fails to mediate p70 S6K activation, consistent with its inability to bind p85 (19) . Moreover, a mutant IRS-1 molecule lacking 18 tyrosine phosphorylation sites (F18 IRS-1 ) fails to bind p85 and activate PI3K and does not mediate insulin-stimulated phosphorylation of 4E-BP1 (17, 34) . Thus, Ser 302 is a specificity determinant in the IRS-1 branch of the insulin/IGF signaling cascades which can control various aspects of the signal.
Replacing Ser 302 with alanine causes a significant inhibition of insulin-stimulated tyrosine phosphorylation of IRS-1. Because Ser 302 has a positive role in IRS-1 tyrosine phosphorylation, its replacement by alanine fails to establish whether this residue is functionally important in the phosphorylated or unphosphorylated state. However, the finding that inhibition of Ser 302 phosphorylation by short term amino acid/glucose starvation also correlates with a decrease in IRS-1 tyrosine phosphorylation, without inhibition of insulin receptor autophosphorylation or Akt phosphorylation, supports the conclusion that Ser 302 phosphorylation might be important 2 (25) . We do not know the mechanism by which Ser 302 phosphorylation has this effect. Ser 302 phosphorylation might stabilize the interaction between the phosphotyrosine binding domain of IRS-1 and the juxtamembrane region of the insulin receptor, which is expected to promote tyrosine phosphorylation. However, Ser 302 phosphorylation might inhibit the recruitment of phosphotyrosine phosphatases or inhibit interactions with serine/threonine kinases that phosphorylate negative regulatory sites. Because the IRS-1-branch of the insulin/IGF signaling cascade plays an important role in protein synthesis, phosphorylation of Ser 302 might serve to attenuate insulin action when nutrients are in short supply (17) .
Regulation of IRS-protein levels and function is an important component of the insulin/IGF response in various tissues (43, 44) . Several mechanisms controlling IRS-protein levels have been investigated, including regulation of IRS-2 gene expression by cAMP-responsive element-binding protein, or proteasome-mediated degradation of IRS-1 and IRS-2 (22, 45, 46) . Regulation of IRS-protein function by serine/threonine phosphorylation mediated by heterologous kinases is also an important control mechanism (47) . Most studies suggest that serine/ threonine phosphorylation inhibits insulin-stimulated tyrosine phosphorylation (9, 48, 50) . However, IRS-proteins contain more than 20 potential serine/threonine phosphorylation sites, and some of these sites are reported to promote tyrosine phosphorylation (51, 52 Ser 302 is not a JNK phosphorylation site. These results reveal the striking site-specific phosphorylation that occurs in IRS-1.
The Ser 302 kinase is unknown; however, inhibition of Ser 302 phosphorylation by wortmannin or rapamycin, and by short term amino acid/glucose starvation, implicates the PI3K/ mTOR cascade. However, Ser 302 is probably not directly phosphorylated by mTOR, because the serine phosphatase inhibitor okadaic acid promotes Ser 302 phosphorylation in a rapamycininsensitive manner. Insulin signaling through mTOR has been shown to inhibit protein phosphatase 2A activity, which might contribute to Ser 302 phosphorylation (42) . However, inhibition of protein phosphatase 2A might be a nonspecific mechanism that would lead to increased phosphorylation of many serine residues in IRS-1.
The PI3K/mTOR/S6K pathway promotes cell growth and proliferation in cell-based experiment and in adult mouse tissues (30, 49) . Deletion of p70 S6K or ribosomal protein S6 in embryonic stem cells or mice reduces the rate of cell proliferation (31) . Consistent with those data, we observed a decrease in insulin/IGF-I-stimulated cell proliferation in 32D cells expressing the Ser 302 to Ala mutation. The decrease in IRS-1 tyrosine phosphorylation and down-regulation of the PI3K/mTOR/S6K pathway is likely responsible for this defect in cell proliferation. Reduction in IRS-1 tyrosine phosphorylation because of mutation of Ser 302 to Ala might partially diminish the transduction of growth signals from IRS-1 to the PI3K/mTOR/S6K pathway, which reduces cell proliferation.
In summary, we showed that insulin/IGF-I stimulates Ser 302 phosphorylation of rat IRS-1 through activation of an mTORdependent pathway. Ser 302 phosphorylation of IRS-1 appears to play a permissive role in insulin-stimulated IRS-1 tyrosine phosphorylation and signal transduction. This result is important because a defect in a positive regulatory IRS-1 Ser/Thr kinase may be another mechanism contributing to insulin resistance. Future studies will reveal the mechanism(s) by which Ser 302 phosphorylation promotes IRS-1 function and at identifying additional phospho Ser/Thr residues that regulate IRS-1. The effects of Ser/Thr phosphorylation on IRS-1 signaling are likely to be of critical importance to our full understanding of insulin action and insulin resistance.
